LEADER 03633nam  2200577Ia 450 
001 9910438009003321
005 20200520144314.0
010   $a1-283-61267-4
010   $a9786613925121
010   $a3-7091-0912-4
024 7 $a10.1007/978-3-7091-0912-0
035   $a(CKB)2670000000250250
035   $a(EBL)973903
035   $a(OCoLC)808123434
035   $a(SSID)ssj0000733412
035   $a(PQKBManifestationID)11400450
035   $a(PQKBTitleCode)TC0000733412
035   $a(PQKBWorkID)10715348
035   $a(PQKB)11177970
035   $a(DE-He213)978-3-7091-0912-0
035   $a(MiAaPQ)EBC973903
035   $a(PPN)168331144
035   $a(EXLCZ)992670000000250250
100   $a20120914h20122013  uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aDrug therapy for the elderly /$fMartin Wehling, editor
205   $a1st ed. 2013.
210   $aNew York $cSpringer$d2012, c2013
215   $a1 online resource (355 p.)
300   $aDescription based upon print version of record.
311   $a3-7091-0911-6 
320   $aIncludes bibliographical references and index.
327   $aForeword -- Part 1: General aspects -- Part 2: Special considerations with regard to organ systems based on geriatric clinical importance -- Part 3: Pharmacotherapy and geriatric syndromes -- Part 4: Further problem areas in gerontopharmacotherapy and pragmatic recommendations.
330   $aWith people aged 65 years and older currently making up the fastest growing age group throughout the world, the demographic revolution of an aging society will inevitably lead to increased pressure to develop a rationalistic and age-tailored process of diagnosis and treatment among the elderly. As aging people often suffer from several chronic diseases and are being treated with multiple medications concurrently, unwanted drug interactions occur more frequently. Whereas recent approaches have recommended to remove particular drugs from the medication regimen to avoid adverse effects, Drug Therapy for the Elderly underlines both indispensable and dispensable elements of drug treatment, providing the practitioner with: - Background information on the elderly population regarding their needs for particular drugs (with an eye to frailty, co-morbidity patterns, and special sensitivities regarding drug metabolism and excretion) - Practical advice about drug treatment surveillance parameters in the elderly - In-depth discussion of drugs in relation to the elderly with specific diagnoses - Integration of multimorbidity/polypharmacy situations into prioritization schemes - A plan for how to deal with the complexity of polypharmacy situations in a five-minute consultation An original classification of drugs is proposed by the editor which relates the power of effects, prognostic data, and tolerability to a prioritization scoring system. This approach is the first to not only provide a negative listing, but also integrates positive data into an overall assessment for drugs fit for the aged. Therefore, Drug Therapy for the Elderly serves as a timely reference for a wide array of physicians.
606   $aGeriatric pharmacology
606   $aOlder people$xDrug use$vHandbooks, manuals, etc
615  0$aGeriatric pharmacology.
615  0$aOlder people$xDrug use
676   $a615.7042
701   $aWehling$b Martin$01750245
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910438009003321
996   $aDrug therapy for the elderly$94184836
997   $aUNINA